Tong Leng Tan

Tong Leng Tan

Auto-generated profile, based on publicly available information

Tong Leng Tan

Department of Orthopaedic Surgery, Tan Tock Seng Hospital, Singapore

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JNJulia Poh Hwee Ng
Julia Poh Hwee Ng
SHSean Wei Loong Ho
Sean Wei Loong Ho
MYMichael Gui Jie Yam
Michael Gui Jie Yam
TTTong Leng Tan
Tong Leng Tan
Background: Schizophrenia impairs a patient’s self-care abilities, which are crucial after a hip fracture. Studies on the outcomes of patients with schizophrenia after a hip fracture are dated. This study aims to investigate the complication rates, 1-year mortality, and functional outcomes of surgically managed hip fractures in elderly patients with schizophrenia. Methods: This is a retrospective, single-institution cohort study based on a prospectively maintained registry of patients with hip fracture. In this study, 3,056 patients who were ≥60 years of age were treated under a geriatric-orthopaedic hip fracture pathway from January 2014 to December 2018. Baseline demographic characteristics and the Modified Barthel Index (MBI) scores were obtained at admission and at 6 months and 1 year after the fracture. Complications from the fracture and the surgical procedure were recorded during a minimum follow-up period of 2 years. A matching process (based on age, sex, and the MBI at admission) of up to 6 patients without schizophrenia per 1 patient with schizophrenia was utilized to increase power. Differences in perioperative, 6-month, and 1-year outcomes were compared for significance among surgically managed patients with schizophrenia and patients without schizophrenia. Results: Thirty-eight patients with schizophrenia were compared with 170 geriatric patients without schizophrenia who underwent a surgical procedure for a hip fracture. Patients with schizophrenia were more likely to be institutionalized postoperatively (26.3% compared with 4.7%; p < 0.001). Patients with schizophrenia had poorer MBI scores at 12 months (76 compared with 90 points; p = 0.006). The 1-year mortality rate was comparable (p = 0.29) between patients with schizophrenia (5.7%) and those without schizophrenia (2.4%). Similar trends in MBI were observed in the conservatively managed group of patients. Conclusions: There was no increase in postoperative complications after a surgical procedure for a hip fracture in elderly patients with schizophrenia. The 1-year mortality after a surgical procedure for hip fracture is similar in both patients with schizophrenia and those without schizophrenia. Patients with schizophrenia and hip fracture who were surgically managed had poorer 1-year functional outcomes compared with patients without schizophrenia matched for age, sex, and MBI at admission. This information will be useful in shared decision-making discussions with patients and families. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

28 November 2019 in Hip & Pelvis
Verified
Journal Article
Open access
PDF file
TTTong Leng Tan
Tong Leng Tan
SHSean Wei Loong Ho
Sean Wei Loong Ho
AGArjunan Edward Kumanan Graetz
Arjunan Edward Kumanan Graetz
EKErnest Beng Kee Kwek
Ernest Beng Kee Kwek
Tan TL, et al. Hip Pelvis. 2019 Dec;31(4):216-223. https://doi.org/10.5371/hp.2019.31.4.216

3 April 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
BTBryan Tan
Bryan Tan
CTChun Yue Tan
Chun Yue Tan
TTTong Leng Tan
Tong Leng Tan
SYSu-Yin Yang
Su-Yin Yang
GCGillian Long Szu Chew
Gillian Long Szu Chew
HNHui Ping Ng
Hui Ping Ng
Background: Knee osteoarthritis (KOA) is one of most prevalent and fastest-growing causes of pain, impaired mobility, and poor quality of life in the rapidly aging population worldwide. There is a lack of high-quality evidence on the efficacy of traditional Chinese medicine (TCM), particularly acupuncture, and a lack of KOA practice guidelines that are tailored to unique population demographics and tropical climates. Objective: Our HARMOKnee (Heat and Acupuncture to Manage Osteoarthritis of the Knee) trial aims to address these gaps by evaluating the short- and medium-term clinical and cost-effectiveness of acupuncture with heat therapy in addition to standard care, compared to standard care alone. Through a robust process and economic evaluation, we aim to inform evidence-based practice for patients with KOA to facilitate the large-scale implementation of a comprehensive and holistic model of care that harmonizes elements of Western medicine and TCM. We hypothesize that acupuncture with heat therapy as an adjunct to standard care is clinically more effective than standard care alone. Methods: A multicenter, pragmatic, parallel-arm, single-blinded, effectiveness-implementation hybrid randomized controlled trial will be conducted. We intend to recruit 100 patients with KOA randomized to either the control arm (standard care only) or intervention arm (acupuncture with heat therapy, in addition to standard care). The inclusion criteria are being a community ambulator and having primary KOA, excluding patients with secondary arthritis or previous knee replacements. The primary outcome measure is the Knee Osteoarthritis Outcome Score at 6 weeks. Secondary outcome measures include psychological, physical, quality of life, satisfaction, and global outcome measures at 6, 12, and 26 weeks. A mixed method approach through an embedded process evaluation will facilitate large-scale implementation. An economic evaluation will be performed to assess financial sustainability. Results: Patient enrollment has been ongoing since August 2022. The recruitment process is anticipated to conclude by July 2024, and the findings will be analyzed and publicized as they are obtained. As of November 6, 2023, our patient enrollment stands at 65 individuals. Conclusions: The findings of our HARMOKnee study will contribute substantial evidence to the current body of literature regarding the effectiveness of acupuncture treatment for KOA. Additionally, we aim to facilitate the creation of standardized national guidelines for evidence-based practice that are specifically tailored to our unique population demographics. Furthermore, we seek to promote the adoption and integration of acupuncture and heat therapy into existing treatment models. Trial Registration: ClinicalTrials.gov NCT05507619; https://clinicaltrials.gov/study/NCT05507619 International Registered Report Identifier (IRRID): DERR1-10.2196/54352

21 May 2024
Verified
Book Chapter
Closed access
PDF file
BVBimal Mayur Kumar Vora
Bimal Mayur Kumar Vora
TTTong Leng Tan
Tong Leng Tan
ATAnkit Tandon
Ankit Tandon

4 October 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RSRavi Shankar
Ravi Shankar
ENEng Chuan Neoh
Eng Chuan Neoh
KCKaren Sui Geok Chua
Karen Sui Geok Chua
TTTong Leng Tan
Tong Leng Tan
MTMatthew Tay
Matthew Tay
POPoo Lee Ong
Poo Lee Ong
Total knee replacement (TKR) is an effective treatment for end-stage knee osteoarthritis (KOA), yet optimal preoperative rehabilitation strategies remain undefined. Robot-assisted rehabilitation offers potential advantages in delivering controlled, intensive, and reproducible exercise protocols for patients with knee osteoarthritis. This early-phase feasibility study evaluated the safety, usability, and patient acceptability of the Knee-LOCOBOT, a novel robotic rehabilitation device designed for patients with KOA. No inference regarding efficacy can be drawn given the absence of a control group, randomization, or blinding. A single-arm feasibility study was conducted at Tan Tock Seng Hospital, Singapore (ClinicalTrials.gov: NCT07539948; NHG DSRB Reference: 2024–3529). Ten patients with KOA were recruited, with nine completing the intervention prior to TKR. Participants underwent four sessions of robot-assisted exercises incorporating cycling, leg press, and isometric quadriceps strengthening modes. Outcome measures included the Oxford Knee Score (OKS), EQ-5D-5 L, Knee Society Score (KSS), 6-Minute Walk Test (6MWT), Timed Up and Go (TUG), 30-second Chair Rise, quadriceps strength, and patient satisfaction survey. Recruitment, retention, and adherence were the primary feasibility outcomes. From 15 patients screened, 10 were enrolled (consent rate 71%, 10 of 14 eligible), of whom nine completed all four sessions, giving a retention rate of 90% (9/10) and 100% session completion and adherence among completers; the single withdrawal was for personal reasons unrelated to the device. A statistically significant within-group change in 6MWT distance was observed (median 291 m to 360 m; median within-participant change + 15 m, mean change + 31 m; p = 0.012, n = 9). In the absence of a control group this change cannot be attributed to the intervention. Right quadriceps strength showed a non-significant numerical increase ( p = 0.05, unadjusted, one of multiple comparisons). Exercised vs. non-exercised limb strength difference was small and non-significant (Cohen’s d = 0.11, p = 0.75). No adverse events were recorded. Patient acceptability was high (88.9% agreement). This small, single-arm, uncontrolled feasibility evaluation in nine selected low-pain KOA patients suggests that four supervised sessions can be completed without recorded adverse events, with high patient acceptability. No conclusions regarding clinical effectiveness or suitability for rehabilitation pathway integration can be drawn. An adequately powered randomised controlled trial is required before any efficacy claims can be made. Trial registration ClinicalTrials.gov, NCT07539948, date of first registration 27/03/2026.

7 November 2023 in JMIR Preprints
Verified
Preprint
Open access
BTBryan Tan
Bryan Tan
CTChun Yue Tan
Chun Yue Tan
TTTong Leng Tan
Tong Leng Tan
SYSu-Yin Yang
Su-Yin Yang
GCGillian Long Szu Chew
Gillian Long Szu Chew
HNHui Ping Ng
Hui Ping Ng
BACKGROUND Knee osteoarthritis (KOA) is one of most prevalent and fastest-growing causes of pain, impaired mobility, and poor quality of life in the rapidly aging population worldwide. There is a lack of high-quality evidence on the efficacy of traditional Chinese medicine (TCM), particularly acupuncture, and a lack of KOA practice guidelines that are tailored to unique population demographics and tropical climates. OBJECTIVE Our HARMOKnee (Heat and Acupuncture to Manage Osteoarthritis of the Knee) trial aims to address these gaps by evaluating the short- and medium-term clinical and cost-effectiveness of acupuncture with heat therapy in addition to standard care, compared to standard care alone. Through a robust process and economic evaluation, we aim to inform evidence-based practice for patients with KOA to facilitate the large-scale implementation of a comprehensive and holistic model of care that harmonizes elements of Western medicine and TCM. We hypothesize that acupuncture with heat therapy as an adjunct to standard care is clinically more effective than standard care alone. METHODS A multicenter, pragmatic, parallel-arm, single-blinded, effectiveness-implementation hybrid randomized controlled trial will be conducted. We intend to recruit 100 patients with KOA randomized to either the control arm (standard care only) or intervention arm (acupuncture with heat therapy, in addition to standard care). The inclusion criteria are being a community ambulator and having primary KOA, excluding patients with secondary arthritis or previous knee replacements. The primary outcome measure is the Knee Osteoarthritis Outcome Score at 6 weeks. Secondary outcome measures include psychological, physical, quality of life, satisfaction, and global outcome measures at 6, 12, and 26 weeks. A mixed method approach through an embedded process evaluation will facilitate large-scale implementation. An economic evaluation will be performed to assess financial sustainability. RESULTS Patient enrollment has been ongoing since August 2022. The recruitment process is anticipated to conclude by July 2024, and the findings will be analyzed and publicized as they are obtained. As of November 6, 2023, our patient enrollment stands at 65 individuals. CONCLUSIONS The findings of our HARMOKnee study will contribute substantial evidence to the current body of literature regarding the effectiveness of acupuncture treatment for KOA. Additionally, we aim to facilitate the creation of standardized national guidelines for evidence-based practice that are specifically tailored to our unique population demographics. Furthermore, we seek to promote the adoption and integration of acupuncture and heat therapy into existing treatment models. CLINICALTRIAL ClinicalTrials.gov NCT05507619; https://clinicaltrials.gov/study/NCT05507619 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/54352